Method of obtaining a measure of blood glucose

• US 6,261,280 B1
• Filed: 04/17/2000
• Issued: 07/17/2001
• Est. Priority Date: 03/22/1999
• Status: Expired due to Term

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Weijand, Koen J., Houben, Richard P. M., Renirie, Alexis C. M.
• Primary Examiner(s): MENDEZ, MANUEL A
• Application Number:
  US09/551,193
• Time in Patent Office: 456 Days
• Field of Search: 607/72, 607/73, 607/74, 604/31, 604/65, 604/500, 604/66
• US Class Current: 604/500
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control

Abstract

There is provided an implantable system and method for monitoring pancreatic beta cell electrical activity in a patient in order to obtain a measure of a patient'"'"'s insulin demand and blood glucose level. A stimulus generator is controlled to deliver stimulus pulses so as to synchronize pancreatic beta cell depolarization, thereby producing an enhanced electrical signal which is sensed and processed. In a specific embodiment, the signal is processed to determine the start and end of beta cell depolarization, from which the depolarization duration is obtained. In order to reduce cardiac interference, each stimulus pulse is timed to be offset from the QRS signal which can interfere with the pancreas sensing. Additionally, the beta cell signals are processed by a correction circuit, e.g., an adaptive filter, to remove QRS artifacts, as well as artifacts from other sources, such as respiration. The thus obtained insulin demand signal is used either to control delivery of insulin from an implanted insulin pump, or to control ongoing pancreatic stimulation of a form to enhance insulin production.

Claims

1. A method of obtaining a measure of blood glucose in a patient, comprising:

(a) delivering at least one stimulus pulse to a location of said patient containing pancreatic beta cells;

(b) sensing the electrical response of said pancreatic beta cells to said stimulus pulse and obtaining a signal representative of said response; and

(c) processing said at least one signal and deriving therefrom a measure of patient blood glucose level.

2. The method as described in claim 1, comprising delivering said at least one stimulus pulse to the patient'"'"'s pancreas, and timing the delivery of said stimulus pulse to occur while the patient'"'"'s pancreatic beta cells are in a quiet phase.

3. The method as described in claim 2, comprising sensing a plurality of pancreatic beta cell depolarization-repolarization cycles, and determining a next anticipated onset of a repolarization phase, and timing said at least one stimulus pulse to be delivered just before the next expected repolarization onset.

4. A method as described in claim 3, comprising sensing QRS signals of said patient'"'"'s heart and controlling said delivery of said at least one stimulus pulse to occur at a time not coincident with the QRS.

5. The method as described in claim 4, comprising sensing the depolarization burst duration of the patient'"'"'s pancreas following a delivered stimulus pulse, and determining blood glucose level as a function of said determined duration.

6. The method as described in claim 1, further comprising delivering stimulus pulses to a predetennined nerve location to synchronize the electrical activity of said pancreatic beta cells.